What Novogene does

Novogene Corporation Inc. is a US-incorporated (California, 2016) multi-omics services provider and the North American operating entity of the broader Novogene Group. The company offers an integrated portfolio spanning genomics (human, plant, animal, microbial WGS/WES; de novo assembly; metagenomics), transcriptomics (mRNA-seq, total RNA-seq, small RNA-seq, ISO-Seq, prokaryotic and metatranscriptomics), single-cell and spatial omics (10x scRNA-seq, Illumina PIP-seq, spatial transcriptomics), epigenomics (WGBS, EM-Seq, DM-Seq, RIP-seq, ChIP-seq, CUT&Tag, ATAC-seq, RRBS), proteomics (DIA quantitative proteomics on Thermo Orbitrap Astral, PTM analysis, Olink), and metabolomics. Services are delivered through two operational production facilities: the Sacramento Sequencing Center (CLIA-certified since 2018, housing NovaSeq X Plus installed in 2023) and the Beaverton Laboratory (opened 2025, with state-of-the-art mass spectrometry). The technology stack integrates six major certified instrumentation platforms (Illumina, PacBio Revio, 10x Genomics, Ultima Genomics, Thermo Fisher Orbitrap Astral, Olink) with proprietary automation (Falcon/Falcon II), an online bioinformatics tool (NovoMagic), and a customer-facing project management system (CSS), supported by 3,034.69 Tflops of high-performance computing capacity.

The business model is a hybrid sales-led / product-led services model. Revenue is generated predominantly on a per-project, per-sample basis (core offering 10x Single Cell RNA-seq from $1,999/sample, 10x Genomics Flex Apex from $899) with optional bioinformatics add-ons, complemented by a self-serve online ordering channel for select services (mRNA-seq, Illumina Lane Sequencing) and an enterprise inside-sales/field-sales motion for complex multi-omics projects. Pricing is promotional with periodic campaigns (e.g., RNA Day 2026 with up to 15% discounts). Customer segments are horizontally distributed across academic institutions, hospitals and clinical research organizations, pharmaceutical and biotechnology companies, and agricultural enterprises, with no disclosed named anchor customers. The company reports 8,000+ organizations served globally, 3M+ samples processed annually, 200,000+ proteomics samples across 250+ species, and 40,000+ scientific publications citing its services, indicating a high-volume, mid-to-low ASP revenue engine.

Name

Novogene

Legal name

Novogene Corporation Inc.

Website

https://novogene.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Novogene Corporation Inc. is a US-based multi-omics services provider offering integrated genomics, transcriptomics, single-cell, epigenomics, proteomics, and metabolomics sequencing from CLIA-certified labs in Sacramento and Beaverton, serving academic, clinical, pharmaceutical, and agricultural customers globally.

Ownership category

akta.pro rank

Product category

Genomics & Multi-omics Sequencing Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industries

Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)

Keywords

• Multi-omics sequencing
• Genomics services
• NGS sequencing
• Proteomics analysis
• Bioinformatics platforms

Headquarters

HQ city

/, /

HQ country

China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. NGS and Multi-Omics Sequencing Services: Project-based laboratory services covering genomics, transcriptomics, epigenomics, proteomics, and metabolomics. Customers submit biological samples and receive sequencing/bioinformatics data. Services are priced per sample or per lane with optional bioinformatics add-ons. Revenue is generated through per-project fees with no recurring subscription component for the core service.
2. Bioinformatics Analysis Services: Standardized and customized bioinformatics analysis delivered as an add-on to core sequencing services or as standalone analysis. RNA Day 2026 promotion offers codes for sequencing with/without bioinformatics analysis (10% and 15% off respectively).
3. Sequencing-Only Services: Customers with pre-prepared libraries can use Novogene's sequencing platforms (Illumina or Ultima Sequencer) on a per-lane or per-sample basis, with pricing based on sequencing format (PE150) and data release options.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Novogene provides multi-omics sequencing and bioinformatics services, including genomics (whole-genome, exome, targeted sequencing), transcriptomics (RNA-seq, single-cell), epigenomics, proteomics, and metabolomics analysis. The company operates CAP-accredited laboratories with advanced NGS platforms and proprietary data-analysis pipelines (Falcon, NovoMagic) to deliver project-based results for academic, clinical, and industrial research customers.

Product overview

Novogene is a multi-omics services provider offering an integrated portfolio of genomics, transcriptomics, single-cell & spatial omics, epigenomics, proteomics, and metabolomics solutions. The core offerings include Human Whole Genome Sequencing, Whole Exome Sequencing, mRNA Sequencing, 10x Single Cell Gene Expression, Spatial Transcriptomics, Whole Genome Bisulfite Sequencing, Quantitative Proteomics (DIA), and Untargeted Metabolomics. These services are delivered through a technology platform that includes the proprietary Falcon automated delivery system, NovoMagic bioinformatics analysis tool, and Customer Service System. Novogene operates as a certified provider for major technology platforms including 10x Genomics, Illumina, Ultima Genomics, PacBio Revio, Thermo Fisher Orbitrap Astral, and Olink, enabling end-to-end solutions from sample preparation through data delivery. The company processes over 3 million samples annually across 8,000+ organizations served, with high-performance computing infrastructure (3,034.69 Tflops) supporting bioinformatics analysis.

Differentiator

Problem solved

Functional benefit

Brands

• Falcon: Proprietary automated intelligent delivery platform that standardizes workflows from sample to data, ensuring reproducibility, rapid turnaround, and flexible project management.
• NovoMagic
• CSS (Customer Service System)

Products and services

• Genomics Sequencing Services Project-based DNA sequencing services covering whole-genome sequencing, whole-exome sequencing, targeted panel sequencing, and resequencing on short-read and long-read platforms, delivered to academic, pharma, and clinical customers.
• Transcriptomics Services Bulk RNA-seq, mRNA-seq, small RNA-seq, and single-cell transcriptomics services that quantify gene expression and characterize cell populations, primarily for academic and pharma research customers.
• Epigenomics Services Epigenomic profiling services including bisulfite sequencing, ChIP-seq, and ATAC-seq to measure DNA methylation, histone modifications, and chromatin accessibility for research customers.
• Proteomics Services LC-MS/MS-based proteomics services including protein identification, quantification, and PTM analysis using Orbitrap Astral instruments, supporting biomarker and translational research at scale.
• Metabolomics Services Untargeted and targeted metabolomics profiling using high-resolution mass spectrometry to identify and quantify small molecules in biological samples for research and pharma customers.
• Single-Cell Sequencing Services Single-cell RNA-seq, single-cell immune profiling, and related single-cell assays using 10x Genomics technology, delivered as a service to academic, pharma, and clinical research teams.
• Falcon Bioinformatics Platform Proprietary cloud-based bioinformatics platform that supports data analysis, visualization, and management for Novogene's multi-omics service customers.
• NovoMagic Data Analysis Platform Proprietary data-analysis platform that provides standardized pipelines and analytical tools for genomic, transcriptomic, and multi-omics datasets generated through Novogene services.
• Clinical Sequencing (CSS) Service CAP-accredited clinical sequencing service that delivers validated NGS workflows for hospital labs and clinical research applications, supported by the CSS platform.

Quantifiable outcome

• 8,000+ organizations served globally
• +5 more outcomes

Segments8 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability4 records

Feature5 records

Partnerships

One partnership is on record.

• Thermo Fisher ScientificcoreTechnology or Integration · 20 May 2026Thermo Fisher Scientific is a key technology partner supplying the Orbitrap Astral mass spectrometry platform for Novogene's quantitative proteomics services. The grand opening of Novogene's Beaverton mass spectrometry lab (May 20, 2026) featured Michelle Steel, VP of Sales for the Americas in Thermo Fisher's Chromatography and Mass Spectrometry Division, highlighting strong collaboration. The Orbitrap Astral platform integrates three complementary mass analyzers (quadrupole, Orbitrap, Astral) enabling industry-leading sensitivity and throughput for proteomics analysis.

Scale indicators7 records

Recent moves12 records

Expansion highlights5 records

Direct peers

• QIAGEN (Genomics Services): QIAGEN provides genomic services and sample technologies used in NGS and multi-omics workflows, competing with Novogene for sample-prep and bioinformatics-enabled sequencing services for academic and clinical customers.
• Eurofins Genomics: Eurofins Genomics operates a global genomics services network offering DNA sequencing, gene synthesis, oligonucleotides, and bioinformatics — directly comparable breadth to Novogene with broader geographic coverage in Europe.
• Azenta Life Sciences (formerly GENEWIZ): Azenta (GENEWIZ) is a U.S.-headquartered NGS and multi-omics services provider serving academic and pharma customers with Sanger, NGS, and synthesis services — directly comparable to Novogene's Sanger/NGS/synthesis offerings.
• BGI Genomics: BGI is the largest global NGS services provider and Novogene's most direct competitor, offering comparable genomic, transcriptomic, and multi-omics services at scale across human, plant, animal, and microbial applications. Both are headquartered in/affiliated with China and compete aggressively on price and turnaround.
• Personalis: Personalis is a cancer-focused genomics services provider offering tumor/normal sequencing, ctDNA, and immune profiling — directly comparable to Novogene's cancer research and pharma biomarker services, with similar CLIA-certified clinical capability.
• NeoGenomics: NeoGenomics is a clinical oncology-focused genomics services lab offering NGS, IHC, and molecular diagnostics. While more clinically oriented than Novogene, it competes in the same pharma biomarker and clinical genomics services market.

Emerging players

• Pacific Biosciences (PacBio): PacBio is a long-read sequencing platform provider whose Revio instruments Novogene uses as a certified service provider. While primarily an instrument company, PacBio is increasingly offering services and competes for long-read sequencing projects.
• 10x Genomics: 10x Genomics is a leading single-cell and spatial biology platform provider whose certified service providers (including Novogene) deliver its assays. 10x is increasingly competing downstream via direct service offerings and adjacent products.

Broad incumbents

• Thermo Fisher Scientific: Thermo Fisher supplies the Orbitrap Astral mass spec platform that Novogene uses for proteomics and is also a broad life sciences tools and services incumbent that competes in adjacent CRO/CDMO and clinical research services markets.
• Illumina: Illumina is the dominant sequencing platform provider whose instruments (including the NovaSeq X Plus installed at Novogene) underpin the entire NGS services market. Through its own services initiatives and BaseSpace, Illumina competes broadly with Novogene and adjacent providers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/NovogeneAmerica
• YouTubeyoutube.com/@Novogene
• Facebookfacebook.com/NovogeneAmerica
• LinkedInlinkedin.com/company/novogene
• Instagraminstagram.com/novogeneamerica

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novogene